2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸ : 2022-04-30±³À°ÀÏÀÚ : 2022-04-30
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽÇ
±³À°ÁÖÁ¦ :
2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ
´ã´çÀÚ : °¡¿ÂÄÁº¥¼Ç
¿¬¶ôó : 02-2038-7988
À̸ÞÀÏ :
gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í ȸ¿ø: »çÀüµî·Ï 20,000¿ø(¿¬È¸ºñ 10,000¿ø Æ÷ÇÔ) ºñȸ¿ø: »çÀüµî·Ï 30,000¿ø °£È£»ç ¹× Àü°øÀÇ: »çÀüµî·Ï ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:00~09:40 Abstract Presentation I ±èÁظð(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:40~09:55 Contemporary Microscopic Concepts of Pathophysiology of Recurrent Cystititis ¿À¹Ì¹Ì(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:55~10:10 Global Perspective on Improving Patient Care in Uncomplicated UTI Á¤ È«(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:10~10:25 Management of Paediatric Recurrent UTIs and Challenges in Special Patient Populations (VUR, BBD) Á¤Àç¹Î(ºÎ»êÀÇ´ë)
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:25~10:45 Panel Discussion À¯±¸ÇÑ(°æÈñÀÇ´ë)
ÈÞ½Ä 04-30 10:45~10:55 Coffee Break ()
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:55~11:10 New Antibacterial Approaches for Chronic Bacterial Prostatitis Á¶ÀÎâ(±¹¸³°æÂûº´¿ø)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:10~11:25 Probiotics to Treat Chronic Bacterial Prostatitis À±Çö½Ä(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:25~11:40 Non-Pharmacological Interventions for Treating CP/CPPS (e.g shockwave therapy ) ±è¿õºó(¼øõÇâÀÇ´ë)
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:40~12:00 Panel Discussion ÀÌÁ¤¿ì(°æÈñÀÇ´ë)
ÈÞ½Ä 04-30 12:15~13:05 Á¡½É½Ä»ç ()
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:05~13:30 Mycoplasma Genitalium À̱æÈ£(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:30~13:55 Biomarker for Interstitial Cystitis ±è¿µÈ£(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:55~14:25 Urinary Tract Infection: Function and Use of the Innate Immune Response ÃÖÇØ¿õ(°í·Á´ëÇб³ »ý¸í°úÇкÎ)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:25~15:05 Abstract Presentation II À±Çϳª(ÀÌÈÀÇ´ë)
ÈÞ½Ä 04-30 15:05~15:20 Coffee Break ()
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:20~15:35 Sexually Transmitted Disease Surveillance (update on the epidemiology) ÃÖÇö¼·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:35~15:50 Key Changes in 2021 CDC Updates Guidance on Treatment of STIs ȲÀÇâ(Àü³²ÀÇ´ë)
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:50~16:05 Panel Discussion ÀåÀÎÈ£(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:05~16:20 Problems in Care of Voiding Dysfunction and Infection Control in Korea ¹è»ó¶ô(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:20~16:35 The Care Center for Voiding Dysfunction and Infection Disease °íÇõÁØ(µ¿¾ÆÀÇ´ë)
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:35~16:50 Panel Discussion Á¤½ÂÀÏ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 09:40~10:00 ¼º¸Å°³ °¨¿° : ¿øÀαÕ, °Ë»ç¹ý, Ä¡·á ¾çÈñÁ¶(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:00~10:20 ºñ´¢±â°è óġ¿Í ¼ö¼ú ÈÄ °¨¿° ¿¹¹æ (Ç×»ýÁ¦ »ç¿ëÀÇ ÀûÀÀÁõ) ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)
Åä·Ð 04-30 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 10:30~10:50 COVID-19 ȯ°æ °ü¸® ½Ç¹« Áöħ: ȯ±â¿Í Ç¥¸é ¼Òµ¶ ¿Àº¸¶÷(¼¿ï´ëÇб³º´¿ø °¨¿°°ü¸®¼¾ÅÍ)
ÈÞ½Ä 04-30 10:50~11:05 Coffee Break ()
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:05~11:25 ºñ´¢³»½Ã°æÀÇ Á¾·ù¿Í Ư¡ : À°¾ÈÀû ¼Ò°ß (Atlas) À¯¼ºÇö(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:25~11:45 ºñ´¢³»½Ã°æ ¼¼Ã´ ¹× ¼Òµ¶ Áöħ ÇѽÃÇö(´Ü±¹´ëÇб³ õ¾Èº´¿ø °¨¿°°ü¸®ÆÀ)
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀÇ½Ç 11:45~12:05 ºñ´¢³»½Ã°æ ¼Òµ¶Á¦ÀÇ Á¾·ù¿Í »ç¿ë¹æ¹ý ÃÖÀº¼÷(Ãæ³²´ëÇб³º´¿ø)
Åä·Ð 04-30 12:05~12:15 ÁúÀÇ ÀÀ´ä ()